Mari Hämäläinen

Medicine & Life Sciences

1. Chondrocytes 100%
2. Ankyrins 83%
3. Vaccinium vitis-idaea 76%
4. Osteoarthritis 55%
5. Inflammation 54%
6. Rheumatoid Arthritis 47%
7. Macrophages 46%
8. Phenotype 46%
9. RNA-Seq 46%
10. pinosylvin 39%
11. muraglitazar 39%
12. Adipokines 39%
13. Complement Factor D 34%
14. Dexamethasone 33%
15. Anti-Inflammatory Agents 32%
16. Urokinase Plasminogen Activator Receptors 32%
17. Gene Expression 31%
18. Asthma 30%
19. Dual Specificity Phosphatase 1 29%
20. Fibrosis 29%
21. Macrophage Activation 29%
22. Interleukin-6 28%
23. Serum 28%
24. Cytokines 27%
25. Waist-Height Ratio 27%
26. apixaban 27%
27. Diazoxide 27%
28. Glycocalyx 26%
29. indium-bleomycin 26%
30. Skin 26%
31. Resistin 26%
32. Remission Induction 25%
33. Edema 25%
34. Blood Pressure 25%
35. Cardiac Volume 24%
36. Metabolic Syndrome 24%
37. Electroconvulsive Therapy 24%
38. Leptin 24%
39. Lung 23%
40. Glucocorticoids 23%
41. Interleukin-1 Receptors 23%
42. Metabolic Diseases 23%
43. Syndecan-1 23%
44. Interleukin-1 23%
45. Ibuprofen 23%
46. Clozapine 23%
47. Glucagon-Like Peptide 1 23%
48. Genes 23%
49. Bleomycin 22%
50. Iliac Artery 22%